Search Results - "Lengvari, I"

PKA-Bad-14-3-3 and Akt-Bad-14-3-3 signaling pathways are involved in the protective effects of PACAP against ischemia/reperfusion-induced cardiomyocyte apoptosis by Rácz, B., Gasz, B., Gallyas, F., Kiss, P., Tamás, A., Szántó, Z., Lubics, A., Lengvári, I., Tóth, G., Hegyi, O., Rőth, E., Reglődi, D.

“…The neuropeptide PACAP (pituitary adenylate cyclase activating polypeptide) and its receptors are widely expressed in the nervous system and various other…”
Get full text

Effect of PACAP in 6-OHDA-induced injury of the substantia nigra in intact young and ovariectomized female rats by Reglödi, D., Lubics, A., Kiss, P., Lengvári, I., Gaszner, B., Tóth, G., Hegyi, O., Tamás, A.

“…Pituitary adenylate cyclase activating polypeptide (PACAP) has neuroprotective effects in various neuronal cultures and in models of brain pathologies in vivo…”
Get full text

Changes in open-field activity and novelty-seeking behavior in periadolescent rats neonatally treated with monosodium glutamate by Kiss, P, Hauser, D, Tamás, A, Lubics, A, Rácz, B, Horvath, Z S, Farkas, J, Zimmermann, F, Stepien, A, Lengvari, I, Reglódi, D

“…Monosodium glutamate (MSG) treatment of neonatal rodents leads to degeneration of the neurons in the arcuate nucleus, inner retinal layers and various other…”
Get full text

Development of neurological reflexes and motor coordination in rats neonatally treated with monosodium glutamate by Kiss, P, Tamas, A, Lubics, A, Szalai, M, Szalontay, L, Lengvari, I, Reglodi, D

“…Monosodium glutamate (MSG) treatment of neonatal rats causes neuronal degeneration in various brain areas and leads to several neurochemical, endocrinological…”
Get full text

Examination of sensorimotor performance following middle cerebral artery occlusion in rats by Reglődi, D, Tamás, A, Lengvári, I

“…Middle cerebral artery occlusion (MCAO) in rats is the most commonly used stroke model. Besides the infarct size, assessment of sensorimotor performance has…”
Get full text

Protective effects of pituitary adenylate cyclase activating polypeptide in endothelial cells against oxidative stress-induced apoptosis by Rácz, B, Gasz, B, Borsiczky, B, Gallyas, F, Tamás, A, Józsa, R, Lubics, A, Kiss, P, Rőth, E, Ferencz, A, Tóth, G, Hegyi, O, Wittmann, I, Lengvári, I, Somogyvári-Vigh, A, Reglődi, D

“…Abstract Pituitary adenylate cyclase activating polypeptide (PACAP) is a widely distributed neuropeptide that has various different functions in the nervous…”
Get full text

Protective Effects of PACAP in Excitotoxic Striatal Lesion by TAMÁS, A., LUBICS, A., LENGVÁRI, I., REGLÓDI, D.

“…:  The present article investigated the effects of pituitary adenylate cyclase‐activating polypeptide (PACAP) treatment in a quinolinic acid (QA)‐induced…”
Get full text

Distribution of PACAP-like immunoreactivity in the nervous system of oligochaeta by Reglödi, D, Lengvari, I, Szelier, M, Vigh, S, Arimura, A

“…The marked similarity between the primary structures of human, other vertebrate, and the invertebrate tunicate PACAP suggests that PACAP is one of the most…”
Get full text

Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis by Gasz, B., Rácz, B., Rőth, E., Borsiczky, B., Ferencz, A., Tamás, A., Cserepes, B., Lubics, A., Gallyas, F., Tóth, G., Lengvári, I., Reglődi, D.

“…Pituitary adenylate cyclase activating polypeptide (PACAP) has well-known neuroprotective effects, and one of the main factors leading to neuroprotection seems…”
Get full text

Comparative Study of the Effects of PACAP in Young, Aging, and Castrated Males in a Rat Model of Parkinson's Disease by REGLÓDI, D., TAMÁS, A., LENGVÁRI, I., TOTH, G., SZALONTAY, L., LUBICS, A.

“…:  We have previously shown that PACAP ameliorates the neurological symptoms and reduces the dopaminergic cell loss in young male rats, in a 6‐hydroxydopamine…”
Get full text

Changes of PACAP levels in the brain show gender differences following short-term water and food deprivation by Kiss, P, Reglődi, D, Tamás, A, Lubics, A, Lengvári, I, Józsa, R, Somogyvári-Vigh, A, Szilvássy, Z, Németh, J

“…Abstract Pituitary adenylate cyclase activating polypeptide (PACAP) is a pleiotropic neuropeptide exerting diverse actions in the central and peripheral…”
Get full text

Effects of Systemic PACAP Treatment in Monosodium Glutamate-Induced Behavioral Changes and Retinal Degeneration by KISS, P., TAMÁS, A., LUBICS, A., LENGVÁRI, I., SZALAI, M., HAUSER, D., HORVATH, Z.S., RACZ, B., GABRIEL, R., BABAI, N., TOTH, G., REGLÓDI, D.

“…:  The present article investigated effects of systemic pituitary adenylate cyclase‐activating polypeptide (PACAP) treatment in monosodium glutamate…”
Get full text

PAC1 receptor localization in a model nervous system: Light and electron microscopic immunocytochemistry on the earthworm ventral nerve cord ganglia by Molnár, L., Pollák, E., Boros, A., Shioda, S., Nakajo, S., Tamás, A., Lengvári, I., Reglődi, D., Lubics, A.

“…The presence and pattern of pituitary adenylate cyclase activating polypeptide (PACAP) type I (PAC1) receptors were identified by means of pre- and…”
Get full text

Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia by Reglodi, D., Tamás, A., Somogyvári-Vigh, A., Szántó, Z., Kertes, E., Lénárd, L., Arimura, A., Lengvári, I.

“…PACAP exerts neuroprotective effects under various neurotoxic conditions in vitro. In vivo, it reduces brain damage after global and transient focal ischemia…”
Get full text

Neurological reflexes and early motor behavior in rats subjected to neonatal hypoxic–ischemic injury by Lubics, Andrea, Reglődi, Dóra, Tamás, Andrea, Kiss, Péter, Szalai, Milán, Szalontay, Luca, Lengvári, István

“…Severe perinatal hypoxia–ischemia is an important cause of brain injury in both full-term and premature newborns, with a high risk of future behavioral and…”
Get full text

PACAP-27 radioimmunoassay: Description and application of a novel method by Nemeth, J, Jakab, B, Jozsa, R, Hollosy, T, Tamas, A, Lubics, A, Lengvari, I, Kiss, P, Oberritter, Zs, Horvath, B, Szilvassy, Z, Reglodi, D

“…Pituitary adenylate cyclase activating polypeptide (PACAP) is a widely distributed neuropeptide that has two molecular forms with 38 and 27 amino acid…”
Get full text

Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson’s disease by Reglődi, Dóra, Lubics, Andrea, Tamás, Andrea, Szalontay, Luca, Lengvári, István

“…Pituitary adenylate cyclase activating polypeptide (PACAP) is a pleiotropic neuropeptide, exerting different actions in the central and peripheral nervous…”
Get full text

Pituitary adenylate cyclase activating polypeptide is highly abundant in the nervous system of anoxia-tolerant turtle, Pseudemys scripta elegans by Reglödi, D, Somogyvári-Vigh, A, Vı́gh, J, Li, M, Lengvári, I, Arimura, A

“…The levels of the pituitary adenylate cyclase activating polypeptide (PACAP) were measured in the central nervous system and in peripheral organs of the…”
Get full text

Age and gender differences in behavioral and morphological outcome after 6-hydroxydopamine-induced lesion of the substantia nigra in rats by Tamás, Andrea, Lubics, Andrea, Szalontay, Luca, Lengvári, István, Reglődi, Dóra

“…It is well known that Parkinson's disease occurs more commonly in older people and men are more frequently affected than women. Animal studies in models of the…”
Get full text

Evidence for a diurnal fluctuation in plasma corticosterone levels after fornix transection in the rat by Lengvári, I, Halász, B

Get more information